马来西亚新山多族裔人群泛发性脓疱型银屑病发病率与患病率:2010至2020年基于电子健康档案的人群队列研究
该研究利用马来西亚Teleprimary Care数据库2010年1月至2020年12月数据,纳入230例皮肤科确诊的泛发性脓疱型银屑病(GPP)患者,估计患病率为198/百万、发病率为27.2/百万人年(95%CI 22.8-31.6),并描述其发作与诱发因素。
要点
- GPP患病率198/百万,女性267、男性127;总发病率27.2/百万人年(95%CI 22.8-31.6)。
- 女性发病率35.3(28.4-42.2)/百万人年,男性18.3(13.1-23.5)/百万人年。
- 67%的GPP患者合并寻常型银屑病(PV),无PV者起病更早且发作更频繁。
核心结论
- 研究结果有助于GPP的全球分布描绘,将帮助指导这一罕见疾病的管理。
研究设计与样本
- 基于人群的队列研究,使用Teleprimary Care数据库2010年1月至2020年12月数据。
- 通过国际疾病分类第10版诊断编码识别230例经皮肤科医生确诊的GPP病例。
- 按年龄、性别和族裔分层计算年患病率与发病率。
- 比较合并寻常型银屑病(PV)与不合并PV的GPP患者的发作及诱发因素。
主要发现
- GPP患病率为198/百万(女性267、男性127),总发病率为27.2/百万人年(95%CI 22.8-31.6)。
- 女性发病率35.3(28.4-42.2)/百万人年,高于男性18.3(13.1-23.5)/百万人年。
- 华裔患病率271/百万、发病率41.6(28.9-54.3)/百万人年,高于马来裔患病率186/百万、发病率24.6(19.4-29.7)/百万人年及印度裔患病率179/百万、发病率25.0(13.8-36.3)/百万人年。
- 67%的GPP患者合并PV;无PV者患病率66/百万 vs 合并PV者132/百万,无PV者发病率19.3(95%CI 15.6-23.0)/百万人年 vs 合并PV者8.0(95%CI 5.6-10.3)/百万人年。
- GPP平均起病年龄42.7岁(SD 18.4),起病年龄呈双峰趋势,第一峰20-29岁、第二峰50-59岁;无PV者起病平均年龄37.5岁(SD 20.7)早于合并PV者44.9岁(SD 17.0),P=0.026。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is limited understanding of the epidemiology of generalized pustular psoriasis (GPP) internationally, with no population-based estimates of GPP in South East Asia. OBJECTIVES: To determine the incidence and prevalence of GPP in the Malaysian population and characterize its flares and trigger factors. METHODS: We conducted a population-based cohort study using the Teleprimary Care database between January 2010 and December 2020. We identified 230 dermatologist-confirmed GPP cases using International Classification of Diseases, 10th revision, diagnostic codes. Annual prevalence and incidence rates were stratified by age, sex and ethnicity. We compared data regarding flares and trigger factors for patients with GPP who had associated psoriasis vulgaris (PV) with those who did not have associated PV. RESULTS: The prevalence of GPP was 198 per million (267 women, 127 men) and incidence was 27.2 per million person-years [95% confidence interval (CI) 22.8-31.6]; 35.3 (28.4-42.2) per million person-years for women and 18.3 (13.1-23.5) per million person-years for men. Rates were higher in Chinese individuals [prevalence 271 per million; incidence 41.6 per million person-years (28.9-54.3)] than in the Malay population [prevalence 186; incidence 24.6 (19.4-29.7)] or the Indian ethnic group [prevalence 179; incidence 25.0 (13.8-36.3)]. Annual prevalence was consistently higher in women than in men and highest among the Chinese population, followed by the Indian and Malay populations. Overall, 67% of patients with GPP had associated PV. The prevalence and incidence of GPP without PV were lower than GPP with PV at 66 vs. 132 per million and 19.3 (95% CI 15.6-23.0) vs. 8.0 (95% CI 5.6-10.3) per million person-years, respectively. The mean age at GPP onset was 42.7 years (SD 18.4). A bimodal trend in the age of GPP onset was observed, with first and second peaks at age 20-29 years and age 50-59 years, respectively. Disease onset was significantly earlier in patients with GPP without PV than in those with PV [mean age 37.5 years (SD 20.7) vs. 44.9 years (SD 17.0), P = 0.026]. Flares occurred more frequently in patients without PV than in those with PV [mean number of flares per patient per year was 1.35 (SD 0.77) vs. 1.25 (SD 0.58), P = 0.039]. Common triggers of flares in patients with GPP who did not have PV were infections, pregnancy, menstruation and stress, whereas withdrawal of therapy, particularly systemic corticosteroids, was a more frequent trigger in patients with GPP who also had PV. CONCLUSIONS: Our findings contribute to the global mapping of GPP, which will help inform the management of this rare condition.
引用
- Choon SE, Wright AK, Griffiths CEM, et al. Incidence and prevalence of generalized pustular psoriasis in multiethnic Johor Bahru, Malaysia: a population-based cohort study using routinely captured electronic health records in the Teleprimary Care (TPC®) clinical information system from 2010 to 2020. Br J Dermatol. 2023. PMID: 37162007. doi:10.1093/bjd/ljad158
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。